Neural Therapeutics Inc. (CSE:NURL)

Canada · Delayed Price · Currency is CAD

0.0200

+0.0050 (33.33%)

At close: Aug 19, 2026

Neural Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Cash & Equivalents	0.06	0.17	0.07	0.27	0.37
Cash & Short-Term Investments	0.06	0.17	0.07	0.27	0.37
Cash Growth	-88.51%	147.61%	-75.56%	-26.50%	-
Other Receivables	0.01	0.01	0.03	0.07	0.05
Receivables	0.01	0.01	0.03	0.07	0.05
Prepaid Expenses	0	0.02	-	0.01	0.03
Other Current Assets	-	-	0	-	-
Total Current Assets	0.07	0.19	0.1	0.35	0.45
Total Assets	1.64	0.19	0.1	0.35	0.45

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Accounts Payable	0.01	0.01	0.06	0.17	0.18
Accrued Expenses	0.17	0.16	0.23	0.3	0.15
Short-Term Debt	-	-	0.01	-	-
Other Current Liabilities	-	-	-	-	0.14
Total Current Liabilities	0.18	0.18	0.31	0.47	0.46
Long-Term Debt	0.8	0.74	0.37	0.14	-
Other Long-Term Liabilities	-	-	0.1	-	-
Total Liabilities	0.99	0.92	0.78	0.61	0.46

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Common Stock	5.38	3.55	2.91	2.31	2.07
Additional Paid-In Capital	0.1	0.1	-	-	-
Retained Earnings	-5.62	-5.16	-4.14	-3.47	-2.39
Comprehensive Income & Other	0.79	0.79	0.54	0.89	0.32
Shareholders' Equity	0.65	-0.73	-0.68	-0.26	-0.01
Total Liabilities & Equity	1.64	0.19	0.1	0.35	0.45

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Total Debt	0.8	0.74	0.38	0.14	-
Net Cash (Debt)	-0.74	-0.58	-0.32	0.13	0.37
Net Cash Growth	-	-	-	-64.04%	-
Net Cash Per Share	-0.01	-0.01	-0.01	0.00	0.01
Filing Date Shares Outstanding	168.7	88.7	65.77	65.77	36.77
Total Common Shares Outstanding	168.7	88.7	65.77	45.07	36.77
Working Capital	-0.11	0.02	-0.21	-0.12	-0.01
Book Value Per Share	0.00	-0.01	-0.01	-0.01	-0.00
Tangible Book Value	0.65	-0.73	-0.68	-0.26	-0.01
Tangible Book Value Per Share	0.00	-0.01	-0.01	-0.01	-0.00